Contract 75F40119C10096
Akina, Inc. · Department Of Health And Human Services · September 25, 2019
Akina, Inc. was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 25, 2019 for $992,000 of work in pharmaceutical preparation manufacturing. Performance is in West Lafayette, IN. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 13, 2021.
Contract details
- PIID
- 75F40119C10096
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- R&D- Medical: Other (Basic Research)
- Place of performance
- West Lafayette, IN
- First action
- September 25, 2019
- Latest action
- September 13, 2021
Description
BAA PMQWP#187 "NEW ANALYTICAL METHODS FOR COMPLEX SAMENESS OF INJECTABLE, LONG-ACTING PLGA FORMULATIONS"
Modification timeline
-
September 13, 2021Mod P00001$264.2K
-
September 25, 2019Base award$728.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40119C10096?
Contract 75F40119C10096 is a federal contract awarded to Akina, Inc. by Department Of Health And Human Services on September 25, 2019 for $992,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75F40119C10096?
Akina, Inc. won contract 75F40119C10096 from Department Of Health And Human Services.
How much is contract 75F40119C10096 worth?
Contract 75F40119C10096 has obligated $992,000 to date.